Droperidol and ondansetron-induced qt interval prolongation: A clinical drug interaction study

Anesthesiology

Volumn 109, Issue 2, 2008, Pages 206-212

  Charbit, Beny ^a   Alvarez, Jean Claude ^d   Dasque, Eric ^d   Abe, Emuri ^c   Démolis, Jean Louis ^d   Funck Brentano, Christian ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d St Antoine University Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

DROPERIDOL; HALOPERIDOL; ONDANSETRON; PLACEBO; TROPISETRON; ANTIEMETIC AGENT;

ABDOMINAL PAIN; ADULT; AGITATION; ANXIETY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RETENTION; DYSKINESIA; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; MALE; MAXIMUM PLASMA CONCENTRATION; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; ELECTROCARDIOGRAPHY; HALF LIFE TIME; LONG QT SYNDROME; METABOLIC CLEARANCE RATE; STATISTICAL MODEL;

ADULT; ANTIEMETICS; AREA UNDER CURVE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DROPERIDOL; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HALF-LIFE; HEART RATE; HUMANS; LINEAR MODELS; LONG QT SYNDROME; MALE; METABOLIC CLEARANCE RATE; ONDANSETRON;

EID: 48849117034     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31817fd8c8     Document Type: Article

References (22)

1. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N: A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350:2441-51
2. Nuttall GA, Eckerman KM, Jacob KA, Pawlaski EM, Wigersma SK, Shirk Marienau ME, Olivier WC, Narr BJ, Ackerman MJ: Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population? ANESTHESIOLOGY 2007; 107:531-6
3. Schwoerer AP, Blutner C, Brandt S, Binder S, Siebrands CC, Ehmke H, Friederich P: Molecular interaction of droperidol with human ether-a-go-go-related gene channels: Prolongation of action potential duration without inducing early afterdepolarization. ANESTHESIOLOGY 2007; 106:967-76
4. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D: Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 2000; 295:614-20
5. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J: Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994; 79:983-6
6. Boike SC, Ilson B, Zariffa N, Jorkasky DK: Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. Am J Health Syst Pharm 1997; 54:1172-6
7. White PF, Song D, Abrao J, Klein KW, Navarette B: Effect of low-dose droperidol on the QT interval during and after general anesthesia: A placebo-controlled study. ANESTHESIOLOGY 2005; 102:1101-5
8. Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J: Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. ANESTHESIOLOGY 2005; 102:1094-100
9. Shah RR: Drugs QTc interval prolongation and final ICH E14 guideline: An important milestone with challenges ahead. Drug Saf 2005; 28:1009-28
10. Chan MT, Choi KC, Gin T, Chui PT, Short TG, Yuen PM, Poon AH, Apfel CC, Gan TJ: The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting. Anesth Analg 2006; 103:1155-62
11. Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013-22
12. Habib AS, Gan TJ: Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96:1377-9
13. Charbit B, Samain E, Merckx P, Funck-Brentano C: QT interval measurement: Evaluation of automatic QTc measurement and new simple method to calculate and interpret corrected QT interval. ANESTHESIOLOGY 2006; 104:255-60
14. Detre E, Thomsen MB, Beekman JD, Petersen KU, Vos MA: Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes. Br J Pharmacol 2005; 145:397-404
15. Drolet B, Zhang S, Deschenes D, Rail J, Nadeau S, Zhou Z, January CT, Turgeon J: Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999; 10:1597-604
16. Fischler M, Bonnet F, Trang H, Jacob L, Levron JC, Flaisler B, Vourc'h G: The pharmacokinetics of droperidol in anesthetized patients. ANESTHESIOLOGY 1986;64: 486-9.
17. Villikka K, Kivisto KT, Neuvonen PJ: The effect of rifampin on the phar-macokinetics of oral and intravenous ondansetron. Clin Pharmacol Ther 1999; 65:377-81
18. Lehmann KA, Van Peer A, Ikonomakis M, Gasparini R, Heykants J: Pharmacokinetics of droperidol in surgical patients under different conditions of anaesthesia. Br J Anaesth 1988; 61:297-301
19. Charbit B, Funck-Brentano C: Droperidol-induced proarrhythmia: The beginning of an answer? ANESTHESIOLOGY 2007; 107:524-6
20. Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN: The QT interval. Prog Cardiovasc Dis 2001; 43:1-45
21. Kang J, Reynolds WP, Chen XL, Ji J, Wang H, Rampe DE: Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. ANESTHESIOLOGY 2006; 104:1015-22
22. Vormberge T, Hoffmann M, Himmel H: Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve. J Pharmacol Toxicol Methods 2006; 54:130-40